This trial will test whether exposure to levels of particulate matter that are close to the current national standard for 24-hour exposure will cause changes in inflammatory and cardiopulmonary function in healthy young people.
4 Primary · 8 Secondary · Reporting Duration: Four days
20 Total Participants · 2 Treatment Groups
Primary Treatment: PM exposure · No Placebo Group · N/A
Age 18 - 35 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: